Goldman Sachs’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $66.4M | Sell |
3,014,114
-687,180
| -19% | -$12M | 0.01% | 1350 |
|
|
2025
Q4 | $43.6M | Buy |
3,701,294
+1,079,012
| +41% | +$13.9M | 0.01% | 1621 |
|
|
2025
Q3 | $41.5M | Buy |
2,622,282
+1,000,081
| +62% | +$14.5M | 0.01% | 1579 |
|
|
2025
Q2 | $18.6M | Buy |
1,622,201
+410,932
| +34% | +$4.63M | ﹤0.01% | 2192 |
|
|
2025
Q1 | $16.4M | Buy |
1,211,269
+377,292
| +45% | +$6.27M | ﹤0.01% | 2213 |
|
|
2024
Q4 | $14.1M | Buy |
833,977
+139,531
| +20% | +$2.71M | ﹤0.01% | 2460 |
|
|
2024
Q3 | $14.1M | Buy |
694,446
+87,817
| +14% | +$1.8M | ﹤0.01% | 2377 |
|
|
2024
Q2 | $13.7M | Sell |
606,629
-14,594
| -2% | -$382K | ﹤0.01% | 2205 |
|
|
2024
Q1 | $16.3M | Sell |
621,223
-38,691
| -6% | -$1.1M | ﹤0.01% | 2017 |
|
|
2023
Q4 | $20.8M | Sell |
659,914
-16,102
| -2% | -$437K | ﹤0.01% | 1843 |
|
|
2023
Q3 | $19M | Sell |
676,016
-15,818
| -2% | -$543K | ﹤0.01% | 1849 |
|
|
2023
Q2 | $25.5M | Sell |
691,834
-22,299
| -3% | -$681K | 0.01% | 1635 |
|
|
2023
Q1 | $21.4M | Sell |
714,133
-264,136
| -27% | -$8.7M | ﹤0.01% | 1765 |
|
|
2022
Q4 | $30M | Sell |
978,269
-247,498
| -20% | -$7.43M | 0.01% | 1593 |
|
|
2022
Q3 | $30.2M | Buy |
1,225,767
+291,076
| +31% | +$9.6M | 0.01% | 1509 |
|
|
2022
Q2 | $29.9M | Sell |
934,691
-565,770
| -38% | -$20.8M | 0.01% | 1560 |
|
|
2022
Q1 | $47.2M | Buy |
1,500,461
+168,809
| +13% | +$5.28M | 0.01% | 1328 |
|
|
2021
Q4 | $44.7M | Buy |
1,331,652
+408,007
| +44% | +$12.7M | 0.01% | 1431 |
|
|
2021
Q3 | $26.8M | Buy |
923,645
+78,295
| +9% | +$2.53M | 0.01% | 1782 |
|
|
2021
Q2 | $29.4M | Sell |
845,350
-112,477
| -12% | -$3.72M | 0.01% | 1719 |
|
|
2021
Q1 | $26.7M | Sell |
957,827
-141,357
| -13% | -$3.76M | 0.01% | 1686 |
|
|
2020
Q4 | $27.2M | Buy |
1,099,184
+19,818
| +2% | +$472K | 0.01% | 1602 |
|
|
2020
Q3 | $22.6M | Buy |
1,079,366
+134,063
| +14% | +$2.59M | 0.01% | 1647 |
|
|
2020
Q2 | $14.5M | Sell |
945,303
-691,995
| -42% | -$8.75M | ﹤0.01% | 1947 |
|
|
2020
Q1 | $14.5M | Sell |
1,637,298
-463,144
| -22% | -$6.68M | 0.01% | 1762 |
|
|
2019
Q4 | $38M | Buy |
2,100,442
+794,239
| +61% | +$13.2M | 0.01% | 1355 |
|
|
2019
Q3 | $19.5M | Sell |
1,306,203
-1,306,020
| -50% | -$21.2M | 0.01% | 1800 |
|
|
2019
Q2 | $62.7M | Buy |
2,612,223
+1,739,281
| +199% | +$51.3M | 0.02% | 995 |
|
|
2019
Q1 | $32.4M | Buy |
872,942
+9,372
| +1% | +$341K | 0.01% | 1463 |
|
|
2018
Q4 | $24.4M | Sell |
863,570
-108,565
| -11% | -$3.43M | 0.01% | 1639 |
|
|
2018
Q3 | $38.3M | Sell |
972,135
-191,687
| -16% | -$8.39M | 0.01% | 1413 |
|
|
2018
Q2 | $51.6M | Buy |
1,163,822
+623,773
| +116% | +$31M | 0.01% | 1194 |
|
|
2018
Q1 | $26.3M | Sell |
540,049
-1,164,239
| -68% | -$58.2M | 0.01% | 1627 |
|
|
2017
Q4 | $85.3M | Sell |
1,704,288
-152,922
| -8% | -$8.01M | 0.02% | 901 |
|
|
2017
Q3 | $94M | Buy |
1,857,210
+56,307
| +3% | +$2.66M | 0.02% | 852 |
|
|
2017
Q2 | $68.3M | Buy |
1,800,903
+885,716
| +97% | +$34.9M | 0.02% | 1039 |
|
|
2017
Q1 | $35.2M | Sell |
915,187
-32,975
| -3% | -$992K | 0.01% | 1464 |
|
|
2016
Q4 | $20.9M | Sell |
948,162
-561,206
| -37% | -$11.5M | 0.01% | 1930 |
|
|
2016
Q3 | $24.1M | Buy |
1,509,368
+428,001
| +40% | +$4.89M | 0.01% | 1745 |
|
|
2016
Q2 | $8.91M | Buy |
1,081,367
+422,614
| +64% | +$3.77M | ﹤0.01% | 2401 |
|
|
2016
Q1 | $4.61M | Sell |
658,753
-443,055
| -40% | -$2.23M | ﹤0.01% | 2782 |
|
|
2015
Q4 | $5.91M | Sell |
1,101,808
-2,726
| -0.2% | -$17.4K | ﹤0.01% | 2677 |
|
|
2015
Q3 | $7.15M | Buy |
+1,104,534
| New | +$11.6M | ﹤0.01% | 2553 |
|
Other funds holding CC
VPM
VCM
WHCM
Goldman Sachs's CC Position: Q1 2026 in Review
Goldman Sachs reduced its Chemours (CC) stake by 19% in Q1 2026, selling an estimated $12M and leaving 3,014,114 shares worth $66.4M. The position accounts for 0.01% of the portfolio, ranked #1350.
Goldman Sachs first reported a position in CC in Q3 2015 and has held it in 43 quarters since. The position peaked at $94M in Q3 2017. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.
- Goldman Sachs held 3,014,114 shares of Chemours worth $66.4M as of Q1 2026.
- Goldman Sachs sold 687,180 Chemours shares in Q1 2026, an estimated $12M.
- Chemours made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1350 holding.
- Goldman Sachs first reported a position in Chemours in Q3 2015 and has held it in 43 quarters since.
- Goldman Sachs's Chemours position peaked at $94M in Q3 2017.
- 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.